Solventum Corp <SOLV.N>: BTIG raises target price to $91 from $89
SOLV•Related News
Longeveron says stem cell therapy laromestrocel reduces neuroinflammation in Phase 2a mild Alzheimer’s trial analysis
LGVN•
Valero Energy Corp <VLO.N>: Raymond James raises target price to $340 from $300
VLO•
Targa Resources Corp. <TRGP.N>: Barclays raises target price to $282 from $270
TRGP•
Venu names ex-ASM Global CEO Ron Bension strategic adviser to CEO Roth
VENU•
Merck & Co Inc <MRK.N>: BMO Raises Target Price to $142 From $135
MRK•